Thomas Moulton, MD (he/him/his)

Senior Medical Director, Hematology
Bayer Pharmaceuticals
Astoria, New York, United States

Thomas Moulton, MD is a senior medical director for Hematology at Bayer Pharmaceuticals US, Medical Affairs.
Residency: Rainbow Babies and Children's hospital, Cleveland OH
Fellowship: Babies Hospital, Columbia Medical Center
In clinical practice over 25 years. Primary clinical research focus was sickle cell disease. Recipient of HRSA sickle cell grant 2011 - 2015.
Also described Hb Bronx, a new beta globin variant causing mild beta thalassemia intermedia
Also described new genetic varitant for Bernard Soulier disease.
Currently at Bayer Pharmaceuticals, US with primary focus on Hemophilia A

Presentation(s):

• PB0672 - Real-World data on Hemophilia A patients switching to either BAY 94-9027 or BAY 81-8973 from Emicizumab using the ATHNdataset

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB1278 - Title: Real-World data on Hemophilia A patients with inhibitors switching to either BAY 94-9027 or BAY 81-8973 in the ATHNdataset

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1291 - Joint range of motion findings among female patients with hemophilia A from the ATHNdataset

  Tuesday, June 27, 2023
  18:30 – 19:30 ET